Mindray and Tencent: Win the first innovative channel product in this field

In January 2021, Mindray Medical signed an AI cooperation framework agreement with Tencent AI Lab.

Recently, the fully automatic peripheral blood cell morphology analyzer jointly developed by Mindray Medical and Tencent AI Lab has completed the special review and announcement of innovative medical devices, and officially entered the NMPA innovation channel. It should be pointed out that this is also the first AI product in the domestic in vitro diagnostic industry to enter the special review process for three types of innovative medical devices.

In terms of blood cell morphology analysis, Tencent AI Lab has adopted a number of self-developed advanced AI computing solutions such as Auto-ML, Auto-Augmentation and NAS. Facing the huge amount of data mixed with noise, the training time is greatly shortened and the number of iterations is increased. . At the same time, algorithm engineers use multi-agent simulation and a decision-making system composed of multiple expert systems to improve the analysis performance of the overall cell morphology, so that abnormal and malignant cells are not missed, and suspected cells are prompted.

In terms of equipment manufacturing, Tencent AI Lab adopts technical solutions such as model compression and computational graph simplification to help products achieve greater advantages in computational efficiency and cost optimization. In addition to morphological detection, Tencent AI Lab also stated that in the future, it will jointly explore the integration and application of artificial intelligence technology in other fields of in vitro diagnosis, such as urine analysis, intelligent laboratory, in vitro diagnosis big data, etc.